drugset / Trial / NCT01713595

Safety Study of Inhaled Saline in Acute Lung Injury

NCT01713595

Phase 1 Withdrawn Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

To determine if an inhaled hypertonic saline solution has any effect on lung function in patients with acute respiratory distress syndrome (ARDS).

Timeline

Start
2013-10
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 5 ml Inhaled
Subject Hypertonic saline Unknown 7 % Inhaled

Indications